(NASDAQ: CLPT) Clearpoint Neuro's forecast annual revenue growth rate of 24.37% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.93%.
Clearpoint Neuro's revenue in 2026 is $40,614,000.On average, 5 Wall Street analysts forecast CLPT's revenue for 2026 to be $1,625,314,356, with the lowest CLPT revenue forecast at $1,528,268,130, and the highest CLPT revenue forecast at $1,694,110,414. On average, 5 Wall Street analysts forecast CLPT's revenue for 2027 to be $1,960,777,608, with the lowest CLPT revenue forecast at $1,763,386,304, and the highest CLPT revenue forecast at $2,138,105,894.
In 2028, CLPT is forecast to generate $2,358,439,213 in revenue, with the lowest revenue forecast at $2,265,951,401 and the highest revenue forecast at $2,427,805,073.